# YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment

> **NCT07409805** · PHASE1 · NOT_YET_RECRUITING · sponsor: **West China Hospital** · enrollment: 9 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** YMN-136 Vaccine

## Key facts

- **NCT ID:** NCT07409805
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-02-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07409805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07409805, "YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07409805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
